Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-CANCER COMPOSITION COMPRISING PATIENT-DERIVED EXOSOME, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/121394
Kind Code:
A1
Abstract:
The present invention relates to an anti-cancer composition comprising a patient-derived exosome, and the use thereof. The present invention may be utilized in the use of a sensitizer which doubles the effect of a patient-specific cancer-specific therapeutic agent as well as other anti-cancer therapeutic agents.

Inventors:
LEE JI YUN (KR)
HYUNG SU JIN (KR)
LIM HO YEONG (KR)
KANG WON KI (KR)
PARK JOON OH (KR)
Application Number:
PCT/KR2022/021193
Publication Date:
June 29, 2023
Filing Date:
December 23, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (KR)
International Classes:
A61K35/12; A23L33/10; A61K9/50; A61K31/337; A61K31/475; A61K31/519; A61K31/555; A61K33/243; A61K45/06; A61P35/00
Foreign References:
KR20170021411A2017-02-28
KR20180005473A2018-01-16
KR20150028652A2015-03-16
Other References:
ZHANG QIUMO, ZHANG HAIYANG, NING TAO, LIU DONGYING, DENG TING, LIU RUI, BAI MING, ZHU KEGAN, LI JIALU, QIAN FAN, YING GUOGUANG, BA: "Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer", INTERNATIONAL JOURNAL OF NANOMEDICINE, vol. 15, 1 January 2020 (2020-01-01), pages 2323 - 2335, XP093074635, DOI: 10.2147/IJN.S231214
HYUNG SUJIN, KO JIHOON, KIM SEUNG, KANG WON KI, LEE JEEYUN: "Exosome in ascites can be a potential therapeutic target for gastric cancer with malignant ascites.", JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16_suppl, 1 January 2022 (2022-01-01), US , pages 1 - 1, XP093075182, ISSN: 0732-183X, DOI: 10.1200/JCO.2022.40.16_suppl.e15008
HYUNG, SUJIN; KO, JIHOON; LEE, IN-KYUNG; JEON, NOO LI; LEE, JEEYUN: "Abstract 6352: Ascites derived exosomes promote progression of advanced gastric cancers", CANCER RESEARCH, vol. 82, no. 12, Suppl., 15 June 2022 (2022-06-15), US, pages 1 - 3, XP009547374, ISSN: 0008-5472, DOI: 10.1158/1538-7445.AM2022-6352
Attorney, Agent or Firm:
JUNGJIN IP LAW FIRM (KR)
Download PDF: